Skip to content

Labcorp Holdings LH Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin28.8%+0.9pp28.8%+0.9pp28.4%+0.5pp28.1%+0.1pp27.9%+0.1pp
Operating margin10.2%+1.9pp9.9%+1.6pp9.7%8.8%8.3%
Net margin6.7%+1.1pp6.3%+0.5pp6.2%5.7%5.5%
EBITDA margin15%+1.8pp14.8%+1.5pp14.6%13.8%13.3%
Free cash flow margin9.8%+1.0pp8.6%+0.2pp10%+3.4pp9.4%+2.5pp8.7%+3.3pp
Returns
Return on equity11.1%+2.1pp10.5%+1.1pp10.1%9.3%9%
Return on assets5.1%+0.9pp4.8%+0.5pp4.6%4.4%4.3%
Return on invested capital9.8%+1.5pp9.7%+1.4pp9.8%9.3%8.3%
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.7×0.0×0.8×+0.1×0.8×+0.1×
Inventory turnover20.4×+0.7×19.3×-0.1×19.6×+0.2×20.4×+1.1×19.7×+1.1×
Liquidity
Current ratio1.7×-0.1×1.4×0.0×1.6×+0.1×1.5×+0.6×1.8×+1.0×
Quick ratio1.5×-0.1×1.2×-0.1×1.4×+0.1×1.3×+0.5×1.6×+0.8×
Cash ratio0.4×+0.2×0.2×-0.3×0.2×-0.2×0.2×+0.2×0.2×+0.2×
Leverage
Debt-to-equity0.8×0.0×0.8×-0.1×0.7×-0.1×0.7×+0.2×0.8×+0.3×
Debt-to-assets0.4×0.0×0.4×0.0×0.3×0.0×0.3×+0.1×0.4×+0.1×
Net debt / EBITDA2.9×-0.6×2.9×-0.4×2.7×2.9×3.5×
Interest coverage6.4×+1.4×6.2×+1.0×5.7×5.2×
Valuation
Market capitalization$21.99B+12.9%$20.8B+8.4%$23.85B+26.9%$21.97B+28.4%$19.48B+6.0%
Enterprise value$28.24B+10.2%$26.79B+7.4%$29.29B+24.1%$27.37B+31.6%$25.63B+15.5%
Price / earnings23.4×-3.3×23.7×-2.0×27.9×28.8×26.7×
Price / sales1.6×+0.1×1.5×0.0×1.7×+0.3×1.6×+0.3×1.5×0.0×
Price / book2.5×+0.2×2.4×0.0×2.7×+0.4×2.6×+0.5×2.3×0.0×
EV / EBITDA13.3×-1.4×13×-1.4×14.6×14.7×14.7×
EV / sales+0.1×1.9×0.0×2.1×+0.3×+0.4×1.9×+0.1×
Free cash flow yield6.3%+0.4pp5.8%+0.1pp5.8%+1.3pp5.7%+0.8pp5.9%+2.3pp
Earnings yield4.3%+0.5pp4.2%+0.3pp3.6%3.5%3.8%
Dividend yield1.1%-0.2pp1.2%-0.1pp1%-0.3pp1.1%-0.3pp1.2%-0.1pp
PEG ratio0.8×1.4×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Labcorp Holdings's profit margins?
Labcorp Holdings (LH) runs a 28.8% gross margin and a 10.2% operating margin, with a 6.7% net margin.
Where do Labcorp Holdings's ratios come from?
Every ratio is computed from Labcorp Holdings's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.